Biotechnology | Disease | FDA | Therapeutics
FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys; Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths
On Jul. 18, 2025, the U.S. Food and Drug Administration (FDA) announced it has placed Sarepta Therapeutics investigational…
